(Q33195011)

23 July 2017

title

Treatment of large facial Bowen's disease: case report (English)

1 reference

23 July 2017

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

1 April 2024

author name string

S. Kossard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616805

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616805

1 April 2024

publication date

1 November 2003

1 reference

full work available at URL

23 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2230.28.s1.5.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2230.28.s1.5.x/fullpdf

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

Clinical and Experimental Dermatology

1 April 2024

published in

1 reference

23 July 2017

volume

28 Suppl 1

1 reference

23 July 2017

page(s)

13-15

1 reference

Imiquimod 5% cream in the treatment of Bowen's disease

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Guidelines for management of Bowen's disease. British Association of Dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Bowen's disease: statistical study of a 10 year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.28.S1.5.X

Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

Body site distribution of Bowen's disease.

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2230.28.S1.5.X

1 April 2024

Identifiers

1 reference

23 July 2017

1 reference